Regional Anesthesia for Broken Arm
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore better pain management for children after surgery on a broken arm, specifically focusing on a closed lateral condyle fracture. Researchers seek to determine if an infraclavicular nerve block (a form of regional anesthesia) administered before surgery can reduce the need for opioids, such as oxycodone, for pain relief. Children with this specific arm fracture who will undergo a particular type of surgery to fix it might be eligible to join. The study aims to improve satisfaction with pain control and reduce opioid use by comparing two groups: one receiving the nerve block and the other following the standard pain management protocol. As a Phase 4 trial, this research focuses on understanding how an already FDA-approved and effective treatment can benefit more patients.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, all patients will receive standard oxycodone solution prescriptions post-operatively.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, all patients will receive standard oxycodone for pain after surgery.
What is the safety track record for the infraclavicular nerve block and the standard preoperative protocol?
Research shows that the infraclavicular nerve block is generally safe for managing pain after arm surgeries. A previous study found this type of anesthesia effectively reduced pain for patients with arm fractures. Although it takes a bit longer to perform, it has proven effective for pain relief.
This treatment is currently in a Phase 4 trial, indicating it has been tested in earlier stages and is considered quite safe. Doctors perform the infraclavicular nerve block with the help of an ultrasound, which allows them to accurately target the nerves. While specific data does not show improved safety with ultrasound, this method is commonly used to enhance accuracy and potentially reduce risks.
Overall, the infraclavicular nerve block is well-tolerated, with few reports of serious side effects. Prospective trial participants should know that research supports this treatment, and it has been used safely in many patients.12345Why are researchers enthusiastic about this study treatment?
Unlike traditional treatments for a broken arm, which typically involve immobilization with a cast or splint and oral pain medications, the infraclavicular nerve block directly targets pain by numbing the nerves in the arm. This method uses ropivacaine, an anesthetic, delivered precisely through ultrasound guidance. Researchers are excited about this approach because it could offer more immediate and effective pain relief compared to oral medications, with potentially fewer systemic side effects. Additionally, the precision of nerve blocks might enhance recovery by allowing patients to begin rehabilitation exercises sooner.
What evidence suggests that the infraclavicular nerve block is effective for post-operative pain control in pediatric patients with broken arms?
Research has shown that an infraclavicular nerve block, a type of regional anesthesia, effectively reduces pain after arm surgeries, including fractures. In this trial, participants in the infraclavicular regional block arm will receive this anesthesia. Studies have found that this method provides better pain relief compared to other nerve blocks, such as supraclavicular nerve blocks, for managing pain in upper limb surgeries. Specifically, some cases demonstrated improved pain relief after surgeries for broken arm bones. This approach may reduce the need for opioid medications by offering better pain control.12367
Are You a Good Fit for This Trial?
This trial is for children with a specific type of broken arm (isolated lateral condyle humerus fracture) that needs surgery to fix it. They must not have other injuries, allergies to ropivacaine or oxycodone, open fractures, swelling needing hospital stays after surgery, or conditions affecting their ability to rate pain using facial expressions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative
Participants are randomized into treatment groups and receive either an infraclavicular nerve block or standard preoperative protocol
Surgery and Immediate Postoperative Care
Participants undergo open reduction and percutaneous pinning, followed by pain management in the PACU
Postoperative Monitoring
Pain levels are assessed using the Wong-Baker FACES scale, and parents complete satisfaction questionnaires and medication logs
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of pain management and side effects
What Are the Treatments Tested in This Trial?
Interventions
- Infraclavicular Nerve Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor